Sfoglia per Autore
Exploring Protein Kinase CK2 Substrate Recognition and the Dynamic Response of Substrate Phosphorylation to Kinase Modulation
2024 Cesaro, Luca; Maria Zuliani, Angelica; BOSELLO TRAVAIN, Valentina; Salvi, Mauro
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant
2024 Borgo, Christian; D'Amore, Claudio; Capurro, Valeria; Tomati, Valeria; Pedemonte, Nicoletta; Bosello Travain, Valentina; Salvi, Mauro
Kinases and Phosphatases: The Challenge of a New Journal Entirely Focused on Post-Translational Modifications
2023 Salvi, Mauro
Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells
2023 Borgo, Christian; Cesaro, Luca; Hirota, Tsuyoshi; Kuwata, Keiko; D'Amore, Claudio; Ruppert, Thomas; Blatnik, Renata; Salvi, Mauro; Pinna, Lorenzo A
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR
2022 D'Amore, Claudio; Borgo, Christian; Bosello Travain, Valentina; Salvi, Mauro
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants
2022 Borgo, Christian; D’Amore, Claudio; Capurro, Valeria; Tomati, Valeria; Sondo, Elvira; Cresta, Federico; Castellani, Carlo; Pedemonte, Nicoletta; Salvi, Mauro
Development of small cyclic peptides targeting the CK2α/β interface
2022 Atkinson, E. L.; Iegre, J.; D'Amore, C.; Brear, P.; Salvi, M.; Hyvonen, M.; Spring, D. R.
Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach
2021 Borgo, C.; Cesaro, L.; Hirota, T.; Kuwata, K.; D'Amore, C.; Ruppert, T.; Blatnik, R.; Salvi, M.; Pinna, L. A.
Editorial of special issue “protein post-translational modifications in signal transduction and diseases”
2021 D'Amore, C.; Salvi, M.
A mutational approach to dissect the functional role of the putative CFTR “PTM-CODE”
2021 D'Amore, C.; Borgo, C.; Salvi, M.
How can a traffic light properly work if it is always green? The paradox of CK2 signaling
2021 Borgo, C.; D'Amore, C.; Cesaro, L.; Sarno, S.; Pinna, L. A.; Ruzzene, M.; Salvi, M.
Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells
2021 Zonta, Francesca; Borgo, Christian; QUEZADA MEZA, CAMILA PAZ; Masgras, Ionica; Rasola, Andrea; Salvi, Mauro; Pinna, Lorenzo A.; Ruzzene, Maria
Protein kinase CK2: a potential therapeutic target for diverse human diseases
2021 Borgo, C.; D'Amore, C.; Sarno, S.; Salvi, M.; Ruzzene, M.
Targeting CK2 in cancer: a valuable strategy or a waste of time?
2021 Salvi, M.; Borgo, C.; Pinna, L. A.; Ruzzene, M.
Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells
2020 Alcaraz, Estefania; Vilardell, Jordi; Borgo, Christian; Sarró, Eduard; Plana, Maria; Marin, Oriano; Pinna, Lorenzo A; Bayascas, José R; Meseguer, Anna; Salvi, Mauro; Itarte, Emilio; Ruzzene, Maria
Non-Histone Protein Methylation: Molecular Mechanisms and Physiopathological Relevance
2020 Salvi, Mauro
Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR
2020 D'Amore, C.; Borgo, C.; Bosello-Travain, V.; Vilardell, J.; Salizzato, V.; Pinna, L. A.; Venerando, A.; Salvi, M.
A N-terminally deleted form of the CK2 alpha' catalytic subunit is sufficient to support cell viability
2020 Borgo, C.; D'Amore, C.; Cesaro, L.; Itami, K.; Hirota, T.; Salvi, M.; Pinna, L. A.
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance
2020 D'Amore, Claudio; Borgo, Christian; Sarno, Stefania; Salvi, Mauro
“Janus” efficacy of CX-5011: CK2 inhibition and methuosis induction by independent mechanisms
2020 D'Amore, C.; Moro, E.; Borgo, C.; Itami, K.; Hirota, T.; Pinna, L. A.; Salvi, M.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile